Subclonal Diversity: Prognostic Role in Acute Myeloid Leukemia Patients with Minimal Residual Disease

Medicine & Life Sciences

1. Residual Neoplasm 100%
2. Acute Myeloid Leukemia 89%
3. Computational Biology 29%
4. Leukemia 25%
5. Data Science 21%
6. Big Data 21%
7. Whole Exome Sequencing 18%
8. Organized Financing 18%
9. Recurrence 17%
10. Preliminary Data 16%
11. Bone Marrow Transplantation 16%
12. Genomics 15%
13. Disease Progression 12%
14. Survival Rate 11%
15. Research Personnel 10%
16. Clinical Trials 10%
17. Biomarkers 10%
18. Drug Therapy 9%
19. Therapeutics 5%